TRIMEDYNE INC
S-2, EX-5, 2001-01-12
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: TRIMEDYNE INC, S-2, EX-1, 2001-01-12
Next: TRIMEDYNE INC, S-2, EX-23, 2001-01-12




                                                               Exhibit 5

                   [HELLER, HOROWITZ & FEIT, P.C., LETTERHEAD]


Trimedyne, Inc.                                           January 12, 2001
2801 Barranca Road
Irvine, CA  92606

Gentlemen:

         As counsel for your  Company,  we have  examined  your  certificate  of
incorporation,   by-laws,  and  such  other  corporate  records,  documents  and
proceedings  and such questions of laws we have deemed  relevant for the purpose
of this opinion.

         We have also, as such counsel, examined the Registration Statement (the
"Registration Statement") of your Company on Form S-2, covering the registration
under the Securities Act of 1933of up to 1,500,000 Shares of Common Stock, $0.01
par value, of the Company ("Common Stock").

         Our review has also  included the exhibits and form of  prospectus  for
the issuance of such securities (the  "Prospectus")  filed with the Registration
Statement.

         On the basis of such examination, we are of the opinion that:

         1. The Company is a corporation  duly  authorized and validly  existing
and in good standing under the laws of the State of Nevada, with corporate power
to conduct its business as described in the Registration Statement.

         2. The Company has an authorized capitalization of 30,000,000 shares of
Common Stock and 1,000,000 shares of Preferred Stock.

         3. The Common Stock has been duly and validly  authorized and, upon the
issuance   thereof,   will  be  duly  and  validly  issued  as  fully  paid  and
non-assessable shares of Common Stock.

         We hereby consent to the use of our name in the Registration  Statement
and  Prospectus  and we also consent to the filing of this opinion as an exhibit
thereto.


                                                  Very truly yours,

                                                  /s/

                                                  HELLER, HOROWITZ & FEIT, P.C.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission